Abbott stock drops, generic competition cited... Despite first-quarter earnings that exceeded expectations with a 13.9% jump in sales, Abbott Laboratories (ABT) stock is going South in a hurry. The firm had an impressive $5.2B in sales and excluding one-time charges, its per share earnings were up 11.8%. But investors were not impressed.
